Related Experiment Video
Updated: Jun 11, 2025
09:04
Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
Published on: March 28, 2025
162
Extracellular vesicles release from protozoa parasite and animal model
Andrey Sladkevicius Vidal1, Rogéria Cristina Zauli1, Wagner Luiz Batista2
1Programa de Pós-Graduação Biologia-Química, Instituto de Ciências Ambientais Químicas e Farmacêuticas, Universidade Federal de São Paulo, Campus Diadema, Diadema, Brazil.
Current Topics in Membranes
|October 6, 2024
Summary
Protozoan parasite diseases like malaria cause significant mortality. Extracellular vesicles (EVs) offer a novel platform for developing affordable treatments and vaccines against these complex parasitic infections.
Area of Science:
- Parasitology
- Biotechnology
- Drug Discovery
Background:
- Protozoan parasite diseases, including leishmaniasis, trypanosomiasis, and malaria, represent a significant global health burden, causing substantial morbidity and mortality.
- Current therapeutic strategies and vaccine development face challenges in complexity and efficacy.
- Environmental biodiversity, drug repositioning, and advanced vaccine technologies are actively explored for novel treatments.
Purpose of the Study:
- To introduce extracellular vesicles (EVs) as a promising therapeutic and vaccine platform for protozoan parasite infections.
- To review the concept, acquisition, and characterization of EVs derived from protozoan parasites.
- To highlight preliminary studies investigating the therapeutic potential of parasite-derived EVs.
Main Methods:
- Conceptual review of extracellular vesicles (EVs).
- Discussion on methods for acquiring and characterizing EVs from protozoan parasites.
- Analysis of existing literature on therapeutic applications of parasite-derived EVs.
Main Results:
- Extracellular vesicles (EVs) can encapsulate parasite antigens, presenting a novel approach for therapeutic and vaccine development.
- EVs offer a potential platform for affordable and effective treatments against parasitic diseases.
- Early research indicates the potential utility of EVs in preclinical models for parasitic infections.
Conclusions:
- Extracellular vesicles (EVs) represent a viable and innovative platform for developing treatments and vaccines against protozoan parasites.
- Further exploration of EVs in animal models is warranted for their biomedical applications in combating parasitic diseases.
- EVs hold promise for advancing the treatment and prevention of leishmaniasis, trypanosomiasis, and malaria.
Related Concept Videos
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
00:51Exocytosis
66.3K
Exocytosis is used to release material from cells. Like other bulk transport mechanisms, exocytosis requires energy.
66.3K
01:33Overview of Secretory Vesicles
8.5K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.5K
01:38Intralumenal Vesicles and Multivesicular Bodies
3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K
01:26Fusion of Secretory Vesicles with the Plasma Membrane
11.0K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.0K
01:27Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...